Studies have shown that LGR5 promotes EMT by activating the Wnt/β-catenin pathway, which promotes the invasion and migration of breast cancer, glioma stem cells, and a variety of other malignant tumors [7, 8]. Here, LGR5 is linked to breast cancer.